DNA damage response deficiency signature predicts response to platinum-based therapy in ovarian cancer

L. A. Hill, J. M. Mulligan, S. Deharo, K. E. Keating, F. A. McDyer, T. S. Davison, C. Gourley, D. P. Harkin, R. D. Kennedy

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)S196-S196
Number of pages1
JournalEuropean Journal of Cancer
Volume49
Publication statusPublished - Sep 2013
Event17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity - Amsterdam, Netherlands
Duration: 27 Sep 20131 Oct 2013

Cite this